About Bazelet Group
We at Bazelet believe that you deserve to feel real relief from a quality and meticulous product that does not compromise on any detail and is served impeccably. The extensive experience in the production processes that we have accumulated over the years of our activity, the research and development department, the quality feedback from thousands of patients on our products, the guidance and accompaniment of patients, the methods of distribution and orders – All of these together allow Bazelet to lead the cannabis industry in Israel, and to provide solutions to patients with medical cannabis.
As with any medical product, high levels of precision and repeatability (consistency, which can be repeated) are key conditions for obtaining optimal treatment – and they will ensure stable and consistent treatment, and avoid unexpected side effects.
In order to receive the most appropriate treatment, Bazelet has developed and manufactures the entire range of compositions approved by the Ministry of Health to treat the approved medical indications under Israeli GMP regulations. These are produced both in products for smoking and vaping (flower) and in tinctures for sublingual administration (oils).
Accuracy and precision
We commit to accuracy in the composition, at a stricter deviation level than the regulatory labels in all products. Keeping the composition the same over time will allow control and confidence in the therapeutic sequence.
Science and Technology
Accuracy, homogeneity and singularity of Bazelet products are possible thanks to 12 years of experience in which extensive scientific, academic and technological knowledge has been assimilated. Basalt’s chief scientist, Prof. Ari Eyal, is a world expert in extraction technologies. Together with experts from the fields of science and technology, the team develops advanced methods dedicated to the medical cannabis industry, which are incorporated into the production procedures.
A technology developed by the Bazelet group guarantees an accurate and uniform product, a challenge that is not applicable in agricultural methods (due to differences in plant genetics and growing conditions). Bazelet GMP facility complies with the strictest standards of the Israeli Ministry of Health and the Medical Cannabis Unit for the creation of products (IMC-GMP). Manufacturing processes that parallel those in the pharmaceutical industry, allow the creation of therapeutic compounds that do not exist in the plant or that cannot be obtained through changes in the plant’s genetics.
Production of a large quantity and a wide variety of medical cannabis products, past and present, combined with scientific research and development established the accumulated experience of Bazelet, and enabled the development of Bazelet’s own brands – Bcann, Femmican, Silver, ASD. All Bazelet product series are accessible to patients according to medical recommendations and are subject to a license from the Israeli Ministry of Health.